[Dosimetry of the hematopoietic system in radioiodine therapy of thyroid cancer].
Twenty patients were submitted to thyroidectomy and treated with iodine-131. Ten out of them received 100 mCi, the other ten 200 mCi. The activity of the total body and of the blood was determined by experimental proceeding. The doses absorbed by blood and bone marrow were calculated on the basis of the experimentally determined values. For the exposure of the blood, a medium value of 0.44 rd/mCi was found after 100 mCi and a medium value of 0.47 rd/mCi after 200 mCi. The corresponding values for the bone marrow are 0.24 and 0.3 rd/mCi, respectively. The total exposure is thus not so high as has been indicated hitherto in literature.
D000328:Adult; D001769:Blood / Q000528:radiation effects*; D001853:Bone Marrow / Q000528:radiation effects*; D003131:Combined Modality Therapy; D004307:Dose-Response Relationship, Radiation; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011879:Radiotherapy Dosage; D013964:Thyroid Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D013965:Thyroidectomy
D007457:Iodine Radioisotopes
Dosimetrie des hämatopoetischen Systems bei der Radiojodtherapie des Schilddrüsenkarzinoms.